AndrewRBranaganMD

Oncology • Boston, MA

Hematologic Oncology

Physician

Join to view full profile

Dr. Branagan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Branagan's full profile

Already have an account?

Office
55 Fruit Street
Boston, MA 02114
Phone+1 617-726-2000
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2010 - 2012
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2009 - 2010
Ben Gurion University of the NegevClass of 2009

Certifications & Licensure

MA State Medical License 2017 - 2024
PA State Medical License 2020 - 2024
MD State Medical License 2021 - 2024
NC State Medical License 2021 - 2023
ME State Medical License 2020 - 2021
CT State Medical License 2014 - 2017
IL State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients Start of enrollment: 2015 Sep 01
Completed
Phase 2
A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients Start of enrollment: 2021 May 13
Active, not recruiting
Phase 1
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy Start of enrollment: 2021 Nov 16
Recruiting
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?
Shayna Sarosiek, Steven P Treon, Andrew R Branagan, Jorge J Castillo> ;Journal of Clinical Oncology. 2023 Aug 20
18 citations
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, Jacob D Soumerai, Andrew J Yee, Andrew R Branagan, Elizabeth K O'Donnell, Anna Saucier, Caron A Jacobs...> ;Blood Cancer Journal. 2022 Nov 1
5 citations
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia.
David Sermer, Shayna Sarosiek, Andrew R Branagan, Steven P Treon, Jorge J Castillo> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Aug 1
5 citations
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma.
Elizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, Omar Nadeem, Jacob P Laubach, Andrew R Branagan, Kenneth C Anderson, Clifton C Mo, Nikhil C Munshi, Irene M Ghobri...> ;Blood Advances. 2022 Sep 13
3 citations
A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.
Manit Munshi, Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R Hunter, M Lia Palomba, Kimon V Argyropoulos, Christopher J Patterson, Alexa...> ;Blood Advances. 2022 Jun 14
12 citations
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.
Elizabeth K O'Donnell, Yael N Shapiro, Andrew J Yee, Omar Nadeem, Bonnie Y Hu, Jacob P Laubach, Andrew R Branagan, Kenneth C Anderson, Clifton C Mo, Nikhil C Munshi, I...> ;Cancer. 2022 May 15
3 citations
Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia.
Shayna Sarosiek, David Sermer, Andrew R Branagan, Steven P Treon, Jorge J Castillo> ;Expert Review of Anticancer Therapy. 2022 May 1
9 citations
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy.
Jorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, Catherine A Flynn, Carly R Leventoff, Timothy P White, Kirsten Meid, Maria L Guerrera, Amanda Kofides, Xia Liu, ...> ;Blood Advances. 2022 Feb 8
41 citations
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
Noopur S Raje, Elias Anaissie, Shaji K Kumar, Sagar Lonial, Thomas Martin, Morie A Gertz, Amrita Krishnan, Parameswaran Hari, Heinz Ludwig, Elizabeth O'Donnell, Andrew...> ;The Lancet. Haematology. 2022 Feb 1
43 citations
Venetoclax in Previously Treated Waldenström Macroglobulinemia
Jorge J. Castillo, John N. Allan, Tanya Siddiqi, Ranjana H. Advani, Kirsten Meid, Carly Leventoff, Timothy P White, Catherine A Flynn, Shayna Sarosiek, Andrew R. Brana...> ;Journal of Clinical Oncology. 2021 Nov 18
28 citations
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
Steven P. Treon, Kirsten Meid, Zachary R. Hunter, Catherine A Flynn, Shayna Sarosiek, Carly Leventoff, Timothy P White, Yang Cao, Aldo M. Roccaro, Antonio Sacco, Maria...> ;Blood. 2021 Oct 28
10 citations
Lifestyle considerations in multiple myeloma
Yael N Shapiro, Jeffrey Peppercorn, Andrew Yee, Andrew R. Branagan, Noopur Raje, Elizabeth K O' Donnell> ;Blood Cancer Journal. 2021 Oct 26
40 citations
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia.
Jorge J. Castillo, Kirsten Meid, Joshua Gustine, Carly Leventoff, Timothy P White, Catherine A Flynn, Shayna Sarosiek, Maria Demos, Maria Luisa Guerrera, Amanda Kofide...> ;Leukemia. 2021 Sep 16
11 citations
Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenström Macroglobulinemia.
Amanda Kofides, Zachary R. Hunter, Lian Xu, Nicholas Tsakmaklis, Maria Demos, Manit Munshi, Xia Liu, Maria Luisa Guerrera, Carly Leventoff, Timothy P White, Catherine ...> ;Hemasphere. 2021 Jul 19
7 citations
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapy.
Joshua Gustine, Shayna Sarosiek, Catherine A Flynn, Kirsten Meid, Carly Leventoff, Timothy P White, Maria Luisa Guerrera, Lian Xu, Amanda Kofides, Nicholas Tsakmaklis,...> ;Haematologica. 2021 Jun 24
7 citations
Cell-free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia.
Maria Demos, Zachary R. Hunter, Lian Xu, Nicholas Tsakmaklis, Amanda Kofides, Manit Munshi, Xia Liu, Maria Luisa Guerrera, Carly Leventoff, Timothy P White, Catherine ...> ;American Journal of Hematology. 2021 Apr 5
13 citations
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemia.
Joshua Gustine, Lian Xu, Guang Yang, Xia Liu, Amanda Kofides, Nicholas Tsakmaklis, Manit Munshi, Maria Demos, Maria Luisa Guerrera, Kirsten Meid, Christopher J. Patter...> ;British Journal of Haematology. 2021 Mar 13
16 citations
Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias.
Andrew R. Branagan, Eamon Duffy, Geliang Gan, Fangyong Li, Connor Foster, Rakesh Verma, Lin Zhang, Terri L. Parker, Stuart Seropian, Dennis L. Cooper, Debra Brandt, Je...> ;Blood Advances. 2021 Mar 9
3 citations
Role of MBD3-SOX2 axis in residual myeloma following pomalidomide
Rakesh Verma, Andrew R. Branagan, Mina L. Xu, Richard A. Flavell, Kavita M. Dhodapkar> ;Leukemia. 2021 Feb 18
2 citations
Clinical application of genomics in Waldenström macroglobulinemia
Andrew R. Branagan, Mathew Lei, Steven P. Treon, Jorge J. Castillo> ;Leukemia & Lymphoma. 2021 Feb 11
78 citations
Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia
Jorge J. Castillo, Ranjana H. Advani, Andrew R. Branagan, Christian Buske, Meletios A. Dimopoulos, Shirley D'Sa, Marie José Kersten, Veronique Leblond, Monique C. Minn...> ;The Lancet. Haematology. 2020 Nov 1
77 citations
Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia
Steven P. Treon, Kirsten Meid, Joshua Gustine, Guang Yang, Lian Xu, Xia Liu, Christopher J. Patterson, Zachary R. Hunter, Andrew R. Branagan, Jacob P. Laubach, Irene M...> ;Journal of Clinical Oncology. 2021 Feb 20
10 citations
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic.
Dipti Talaulikar, Ranjana H. Advani, Andrew R. Branagan, Christian Buske, Meletios A. Dimopoulos, Shirley D'Sa, Maria Jose Kersten, Veronique Leblond, Monique C. Minne...> ;Hemasphere. 2020 Jul 30
82 citations
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P. Treon, Lian Xu, Maria Luisa Guerrera, Cristina Jimenez, Zachary R. Hunter, Xia Liu, Maria Demos, Joshua Gustine, Gloria Chan, Manit Munshi, Nicholas Tsakmakl...> ;Journal of Clinical Oncology. 2020 Feb 21
14 citations
Current Treatment Strategies for Multiple Myeloma.
Andrew R. Branagan, Matthew Lei, Uvette Lou, Noopur Raje> ;JCO Oncology Practice. 2020 Jan 10
Join now to see all

Abstracts/Posters

A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Andrew R. Branagan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Adult Clinical Malignant Hematology
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

Patients with Multiple Myeloma and Waldenström Macroglobulinemia Have Impaired COVID-19 Vaccine ResponsivenessDecember 11th, 2021
Dr. Branagan on Tandem Transplants in Multiple MyelomaMarch 2nd, 2020
More Work Needed to Determine Best Treatment for High-Risk MyelomaFebruary 29th, 2020
Join now to see all